Intelligent assessment: Putting emerging biotechnology threats in context

By | January 1, 2013

One of the problems with assessing the emerging threats from advances in biotechnology and the life sciences is that there are two competing narratives for understanding biotechnology development: one based on the notion of a biotech revolution and the other based on biotech evolution. The biotech revolution is a dystopian tale in which scientific advances lead to rapid changes in biotechnology, its applications, and its potential threats. The biotech evolution, however, describes slower and more complex trajectories for biotechnology development and threats. These two narratives are based on different assumptions and analytic methods, which lead to fundamentally different conclusions. The US intelligence and policy communities use the biotech revolution story line to make sense of today’s bioweapons threats, but this approach fails to reflect the complex social, economic, scientific, and technical factors that shape biotechnology and life science developments. The author argues that more critical perspectives on biotechnology are needed in order to improve intelligence assessments of present and future bioweapons threats and policy regarding them.

Together, we make the world safer.

The Bulletin elevates expert voices above the noise. But as an independent nonprofit organization, our operations depend on the support of readers like you. Help us continue to deliver quality journalism that holds leaders accountable. Your support of our work at any level is important. In return, we promise our coverage will be understandable, influential, vigilant, solution-oriented, and fair-minded. Together we can make a difference.

Get alerts about this thread
Notify of
Inline Feedbacks
View all comments